TY  - GEN
AU  - Duiker,Evelien W
AU  - de Vries,Elisabeth G E
AU  - Mahalingam,Devalingam
AU  - Meersma,Gert Jan
AU  - Boersma-van Ek,Wytske
AU  - Hollema,Harry
AU  - Lub-de Hooge,Marjolijn N
AU  - van Dam,Go M
AU  - Cool,Robbert H
AU  - Quax,Wim J
AU  - Samali,Afshin
AU  - van der Zee,Ate G J
AU  - de Jong,Steven
TI  - Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model
SN  - 1078-0432
PY  - 2009///0416
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Caspase 3
KW  - metabolism
KW  - Cell Line, Tumor
KW  - Cisplatin
KW  - Female
KW  - Humans
KW  - Luminescent Measurements
KW  - Mice
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - Recombinant Proteins
KW  - TNF-Related Apoptosis-Inducing Ligand
KW  - pharmacokinetics
KW  - Tissue Distribution
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-08-1535
ER  -